pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-4323 |
Genomic Coordinates | chr19: 42133445 - 42133513 |
Description | Homo sapiens miR-4323 stem-loop |
Comment | None |
RNA Secondary Structure |
Mature miRNA Information | |||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-4323 | ||||||||||||||||||
Sequence | 42| CAGCCCCACAGCCUCAGA |59 | ||||||||||||||||||
Evidence | Experimental | ||||||||||||||||||
Experiments | SOLiD | ||||||||||||||||||
SNPs in miRNA |
|
||||||||||||||||||
Putative Targets |
miRNA Expression profile | |
---|---|
Human miRNA Tissue Atlas | |
Circulating MicroRNA Expression Profiling |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | ANKRD65 | ||||||||||||||||||||
Synonyms | - | ||||||||||||||||||||
Description | ankyrin repeat domain 65 | ||||||||||||||||||||
Transcript | NM_001145210 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on ANKRD65 | |||||||||||||||||||||
3'UTR of ANKRD65 (miRNA target sites are highlighted) |
>ANKRD65|NM_001145210|3'UTR 1 GCCAGACAGCAGGCTCCAGGCTCCACCGCCCCAGTGATTTCCAGGCTCTCTGGCTGAGGCTGCCTGCCTGGAGGGGACAT 81 CAGGGAAGAGGCTTCCGGAGGAGGGGATGGGAGAAAGTAGGGGATGTGGCTTGAGCTGCAGTCACAGGCCTTGGCTGGAC 161 CAGGGATGGCCCCCAGCTCCCAGGAGGGCCCACTGACCCTGCAGCTCCAGCCTTCTCCATACTTCAACAAAGAATGAGTT 241 GTGGCAATGAGGGAAGAGAGACCCTCTCATAGTGTTTTATACTCAGTACCTGTTTTAAGAAAAAACAACAAGGAAGTAAA 321 ACCAAAGACAGGCAGGCAGCCTGGCGCTAGGCCCGAAACCAGGCCTGCGCCTGCCTGGCCTAAACCCAGTAGTTGAAAAT 401 CAATTCATAACTTAGAAACCGATGTTATTCATAGATTCCAGACATTGTATAGAAGAACATTTGTGAAACTCCCTGCCGTG 481 TTCTGTTTCTCTCTGACCGCCGGTGCATGCAGCCCCTGTCACGTACCGCCTGCTTGCTCAAATCAATGACGACCCTTTCA 561 TGTGAAATCTTCGGTGTTGTGAGCCCTTAAAAGGGACAGAAATTGTGCACTTGGGGAGCTCGGATTTTAAGGCAGTAGCT 641 TGCCGATGCTCCCAGCTGAATAAAGCCCTTCCTTCTACAAAAAAAAAAAAAAA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |||||||
---|---|---|---|---|---|---|---|
miRNA:Target | ---- | ||||||
Validation Method |
|
||||||
Conditions | LCL-BACD3 | ||||||
Disease | MIMAT0016875 | ||||||
Location of target site | 3'UTR | ||||||
Tools used in this research | TargetScan , miRTarCLIP , Piranha | ||||||
Original Description (Extracted from the article) |
...
"PAR-CLIP data was present in GSM1020025. RNA binding protein: AGO2. Condition:EBV B95-8-infected
... - Skalsky RL; Corcoran DL; Gottwein E; Frank et al., 2012, PLoS pathogens. |
||||||
miRNA-target interactions (Provided by authors) |
|
||||||
Article |
- Skalsky RL; Corcoran DL; Gottwein E; Frank et al. - PLoS pathogens, 2012
Epstein-Barr virus (EBV) is a ubiquitous human herpesvirus linked to a number of B cell cancers and lymphoproliferative disorders. During latent infection, EBV expresses 25 viral pre-microRNAs (miRNAs) and induces the expression of specific host miRNAs, such as miR-155 and miR-21, which potentially play a role in viral oncogenesis. To date, only a limited number of EBV miRNA targets have been identified; thus, the role of EBV miRNAs in viral pathogenesis and/or lymphomagenesis is not well defined. Here, we used photoactivatable ribonucleoside-enhanced crosslinking and immunoprecipitation (PAR-CLIP) combined with deep sequencing and computational analysis to comprehensively examine the viral and cellular miRNA targetome in EBV strain B95-8-infected lymphoblastoid cell lines (LCLs). We identified 7,827 miRNA-interaction sites in 3,492 cellular 3'UTRs. 531 of these sites contained seed matches to viral miRNAs. 24 PAR-CLIP-identified miRNA:3'UTR interactions were confirmed by reporter assays. Our results reveal that EBV miRNAs predominantly target cellular transcripts during latent infection, thereby manipulating the host environment. Furthermore, targets of EBV miRNAs are involved in multiple cellular processes that are directly relevant to viral infection, including innate immunity, cell survival, and cell proliferation. Finally, we present evidence that myc-regulated host miRNAs from the miR-17/92 cluster can regulate latent viral gene expression. This comprehensive survey of the miRNA targetome in EBV-infected B cells represents a key step towards defining the functions of EBV-encoded miRNAs, and potentially, identifying novel therapeutic targets for EBV-associated malignancies.
LinkOut: [PMID: 22291592]
|
CLIP-seq Support 1 for dataset GSM1020025 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | LCL-BACD3 / EBV B95-8-infected, 4-thiouridine, RNase T1 |
Location of target site | ENST00000520296.1 | 3UTR | gccuaccguggggcuu |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 22291592 / GSE41437 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | |||||||
---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | |||||||
---|---|---|---|---|---|---|---|
|
64 hsa-miR-4323 Target Genes:
Functional analysis:
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT052834 | NOL11 | nucleolar protein 11 | 1 | 1 | ||||||||
MIRT082489 | PPP1R37 | protein phosphatase 1 regulatory subunit 37 | 2 | 2 | ||||||||
MIRT117166 | PER1 | period circadian clock 1 | 2 | 2 | ||||||||
MIRT157951 | TMEM184B | transmembrane protein 184B | 2 | 2 | ||||||||
MIRT286013 | TVP23B | trans-golgi network vesicle protein 23 homolog B | 2 | 2 | ||||||||
MIRT310457 | REST | RE1 silencing transcription factor | 2 | 2 | ||||||||
MIRT338984 | CPSF6 | cleavage and polyadenylation specific factor 6 | 2 | 2 | ||||||||
MIRT404223 | RPL7L1 | ribosomal protein L7 like 1 | 2 | 2 | ||||||||
MIRT451439 | TJP3 | tight junction protein 3 | 2 | 2 | ||||||||
MIRT463541 | ZBTB7A | zinc finger and BTB domain containing 7A | 2 | 2 | ||||||||
MIRT466981 | STARD7 | StAR related lipid transfer domain containing 7 | 2 | 4 | ||||||||
MIRT479627 | CDC25A | cell division cycle 25A | 2 | 2 | ||||||||
MIRT487983 | SEC14L3 | SEC14 like lipid binding 3 | 2 | 4 | ||||||||
MIRT488661 | ELAVL3 | ELAV like RNA binding protein 3 | 2 | 2 | ||||||||
MIRT489925 | RTKN | rhotekin | 2 | 2 | ||||||||
MIRT490209 | PKNOX2 | PBX/knotted 1 homeobox 2 | 2 | 2 | ||||||||
MIRT494896 | ZNF662 | zinc finger protein 662 | 2 | 2 | ||||||||
MIRT495380 | RELT | RELT, TNF receptor | 2 | 2 | ||||||||
MIRT495549 | ANKRD65 | ankyrin repeat domain 65 | 2 | 2 | ||||||||
MIRT499104 | AGRN | agrin | 2 | 2 | ||||||||
MIRT500036 | ABCF2 | ATP binding cassette subfamily F member 2 | 2 | 8 | ||||||||
MIRT501135 | SLC2A1 | solute carrier family 2 member 1 | 2 | 2 | ||||||||
MIRT505573 | SMC1A | structural maintenance of chromosomes 1A | 2 | 6 | ||||||||
MIRT508164 | ABCC5 | ATP binding cassette subfamily C member 5 | 2 | 8 | ||||||||
MIRT512383 | PHB2 | prohibitin 2 | 2 | 2 | ||||||||
MIRT512719 | YWHAZ | tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein zeta | 2 | 2 | ||||||||
MIRT520904 | STMN1 | stathmin 1 | 2 | 2 | ||||||||
MIRT526361 | TIMMDC1 | translocase of inner mitochondrial membrane domain containing 1 | 2 | 2 | ||||||||
MIRT526847 | GALNT11 | polypeptide N-acetylgalactosaminyltransferase 11 | 2 | 2 | ||||||||
MIRT526945 | CMSS1 | cms1 ribosomal small subunit homolog (yeast) | 2 | 4 | ||||||||
MIRT527028 | PABPN1L | poly(A) binding protein nuclear 1 like, cytoplasmic | 2 | 2 | ||||||||
MIRT527988 | TSLP | thymic stromal lymphopoietin | 2 | 2 | ||||||||
MIRT532202 | MPDU1 | mannose-P-dolichol utilization defect 1 | 2 | 2 | ||||||||
MIRT533691 | TMEM86A | transmembrane protein 86A | 2 | 2 | ||||||||
MIRT535020 | PRMT7 | protein arginine methyltransferase 7 | 2 | 4 | ||||||||
MIRT535054 | PQLC1 | PQ loop repeat containing 1 | 2 | 2 | ||||||||
MIRT538987 | BCL2L2 | BCL2 like 2 | 2 | 2 | ||||||||
MIRT552232 | SART3 | squamous cell carcinoma antigen recognized by T-cells 3 | 2 | 2 | ||||||||
MIRT553259 | TVP23C | trans-golgi network vesicle protein 23 homolog C | 2 | 2 | ||||||||
MIRT555157 | PTPDC1 | protein tyrosine phosphatase domain containing 1 | 2 | 2 | ||||||||
MIRT565202 | TSC22D4 | TSC22 domain family member 4 | 2 | 2 | ||||||||
MIRT566199 | PTP4A1 | protein tyrosine phosphatase type IVA, member 1 | 2 | 2 | ||||||||
MIRT566526 | PARP16 | poly(ADP-ribose) polymerase family member 16 | 2 | 2 | ||||||||
MIRT568464 | ARPP19 | cAMP regulated phosphoprotein 19 | 2 | 2 | ||||||||
MIRT572231 | ATG2A | autophagy related 2A | 2 | 2 | ||||||||
MIRT573096 | NDUFA7 | NADH:ubiquinone oxidoreductase subunit A7 | 2 | 2 | ||||||||
MIRT573326 | RFC5 | replication factor C subunit 5 | 2 | 2 | ||||||||
MIRT632802 | KIAA2022 | neurite extension and migration factor | 2 | 2 | ||||||||
MIRT646433 | ARAP1 | ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 1 | 2 | 3 | ||||||||
MIRT647826 | MTG1 | mitochondrial ribosome associated GTPase 1 | 2 | 4 | ||||||||
MIRT652191 | TRIM44 | tripartite motif containing 44 | 2 | 2 | ||||||||
MIRT653800 | SIRPA | signal regulatory protein alpha | 2 | 2 | ||||||||
MIRT666949 | PKHD1 | PKHD1, fibrocystin/polyductin | 2 | 2 | ||||||||
MIRT684833 | SCAI | suppressor of cancer cell invasion | 2 | 2 | ||||||||
MIRT687294 | PARP2 | poly(ADP-ribose) polymerase 2 | 2 | 2 | ||||||||
MIRT700188 | RIMKLB | ribosomal modification protein rimK like family member B | 2 | 2 | ||||||||
MIRT701784 | MSL2 | MSL complex subunit 2 | 2 | 2 | ||||||||
MIRT705958 | ACY1 | aminoacylase 1 | 2 | 2 | ||||||||
MIRT705998 | ABHD14A-ACY1 | ABHD14A-ACY1 readthrough | 2 | 2 | ||||||||
MIRT717107 | PXDC1 | PX domain containing 1 | 2 | 2 | ||||||||
MIRT717586 | VTA1 | vesicle trafficking 1 | 2 | 2 | ||||||||
MIRT722148 | SLC2A8 | solute carrier family 2 member 8 | 2 | 2 | ||||||||
MIRT723479 | WIPF2 | WAS/WASL interacting protein family member 2 | 2 | 2 | ||||||||
MIRT725221 | PEA15 | phosphoprotein enriched in astrocytes 15 | 2 | 2 |
miRNA-Drug Associations | ||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|